Comment on UK biotech startup raises $100M for next-gen vaccines for respiratory viruses

UK biotech startup raises $100M for next-gen vaccines for respiratory viruses

The vaccine market might be a crowded one, but London-based Vicebio aspires to cement its own place within it. The startup announced today it has raised $100mn in Series B funding for the development of its next-generation vaccines for respiratory viruses. Vicebio aims to deliver vaccines that are highly effective, easy to manufacture, and ready-to-use in prefilled syringes.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News